Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2026
Employees
74,000
Stocks News & Analysis
stocks
The ASX data center stock flying under the radar
stocks
What did Morningstar subscribers buy and sell during June?
stocks
Australia’s largest gold miner downgraded on a falling gold price
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,038.10 | 12.50 | -0.14% |
| CAC 40 | 8,366.85 | 2.20 | 0.03% |
| DAX 40 | 25,147.03 | 32.78 | 0.13% |
| Dow JONES (US) | 52,508.27 | 9.63 | 0.02% |
| FTSE 100 | 10,529.39 | 31.10 | 0.30% |
| HKSE | 24,680.93 | 340.20 | 1.40% |
| NASDAQ | 26,107.01 | 233.83 | 0.90% |
| Nikkei 225 | 68,353.91 | 610.41 | 0.90% |
| NZX 50 Index | 13,619.47 | 31.75 | -0.23% |
| S&P 500 | 7,543.59 | 28.25 | 0.38% |
| S&P/ASX 200 | 8,844.00 | 13.00 | -0.15% |
| SSE Composite Index | 3,972.62 | 5.49 | 0.14% |